Keating Financial Advisory Services’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16K Hold
77
– – ﹤0.01% 2129
2026
Q1
$1.48K Buy
+77
New +$1.67K ﹤0.01% 1959

Other funds holding TNDM

Keating Financial Advisory Services's TNDM Position: Q2 2026 in Review

Keating Financial Advisory Services held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 77 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2129.

Keating Financial Advisory Services first reported a position in TNDM in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.48K in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Keating Financial Advisory Services held 77 shares of Tandem Diabetes Care worth $1.16K as of Q2 2026.
  • Keating Financial Advisory Services left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #2129 holding.
  • Keating Financial Advisory Services first reported a position in Tandem Diabetes Care in Q1 2026 and has held it in 2 quarters since.
  • Keating Financial Advisory Services's Tandem Diabetes Care position peaked at $1.48K in Q1 2026.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.